Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis

Disease Treatment ◽

O117 Cardiovascular disease and impoverishment averted due to a salt reduction program in South Africa: an extended cost-effectiveness analysis

Global Heart ◽

10.1016/j.gheart.2014.03.1328 ◽

2014 ◽

Vol 9 (1) ◽

pp. e31-e32 ◽

Cited By ~ 1

Author(s):

David Watkins ◽

Zachary Olson ◽

Stephane Verguet ◽

Dean Jamison ◽

Rachel Nugent

Keyword(s):

South Africa ◽

Cardiovascular Disease ◽

Cost Effectiveness ◽

Salt Reduction ◽

Effectiveness Analysis ◽

Reduction Program

Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis

Health Policy and Planning ◽

10.1093/heapol/czv023 ◽

2015 ◽

Vol 31 (1) ◽

pp. 75-82 ◽

Cited By ~ 26

Author(s):

David A Watkins ◽

Zachary D Olson ◽

Stéphane Verguet ◽

Rachel A Nugent ◽

Dean T Jamison

Keyword(s):

South Africa ◽

Cardiovascular Disease ◽

Cost Effectiveness ◽

Salt Reduction ◽

Cost-effectiveness analysis of a kidney and cardiovascular disease treatment program in an Australian Aboriginal population

Advances in Chronic Kidney Disease ◽

10.1053/j.ackd.2004.10.001 ◽

2005 ◽

Vol 12 (1) ◽

pp. 22-31 ◽

Cited By ~ 19

Author(s):

Philip R. Baker ◽

Wendy E. Hoy ◽

Roger E. Thomas

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Treatment Program ◽

Disease Treatment ◽

Aboriginal Population ◽

Australian Aboriginal ◽

Cost-Effectiveness Analysis of Cardiovascular Disease Treatment in Japan

International Heart Journal ◽

10.1536/ihj.17-365 ◽

2017 ◽

Vol 58 (6) ◽

pp. 847-852 ◽

Cited By ~ 12

Author(s):

Satoshi Kodera ◽

Arihiro Kiyosue ◽

Jiro Ando ◽

Hiroshi Akazawa ◽

Hiroyuki Morita ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Disease Treatment ◽

Cost effectiveness analysis of a next generation risk assessment score for cardiovascular disease

Journal of Medical Economics ◽

10.3111/13696998.2013.869500 ◽

2013 ◽

Vol 17 (2) ◽

pp. 132-141

Author(s):

Evangelos Hytopoulos ◽

Martin L. Lee ◽

Michael Beggs ◽

Cynthia French ◽

Kuo Bianchini Tong

Keyword(s):

Cardiovascular Disease ◽

Risk Assessment ◽

Cost Effectiveness ◽

Next Generation ◽

Assessment Score ◽

A Framework for the Cost-Effectiveness Analysis of Novel Biomarker Testing in Cardiovascular Disease

Value in Health ◽

10.1016/j.jval.2017.08.040 ◽

2017 ◽

Vol 20 (9) ◽

pp. A404-A405

Author(s):

CN Kohli-Lynch ◽

K Boyd ◽

A Briggs ◽

C Delles

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Biomarker Testing ◽

The Cost

Cost-effectiveness analysis of introducing HTLV-1 testing in South Africa

Retrovirology ◽

10.1186/1742-4690-12-s1-p81 ◽

2015 ◽

Vol 12 (S1) ◽

Author(s):

Wendy Sykes ◽

Charl Coleman ◽

Genevieve Beck ◽

Jabu Mhlanga ◽

Carol Hlela ◽

...

Keyword(s):

South Africa ◽

Cost Effectiveness ◽

First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial

AIDS ◽

10.1097/qad.0b013e3283428cbe ◽

2011 ◽

Vol 25 (4) ◽

pp. 479-492 ◽

Cited By ~ 21

Author(s):

Andrea L Ciaranello ◽

Shahin Lockman ◽

Kenneth A Freedberg ◽

Michael Hughes ◽

Jennifer Chu ◽

...

Keyword(s):

South Africa ◽

Single Dose ◽

Cost Effectiveness ◽

Antiretroviral Therapy ◽

First Line ◽

Effectiveness Analysis ◽

Single Dose Nevirapine

Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease

Diabetes Therapy ◽

10.1007/s13300-019-00701-3 ◽

2019 ◽

Vol 10 (6) ◽

pp. 2153-2167 ◽

Cited By ~ 7

Author(s):

Mafalda Ramos ◽

Volker Foos ◽

Anastasia Ustyugova ◽

Nikco Hau ◽

Pranav Gandhi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Cost Effectiveness ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials ◽

A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?

Genetics in Medicine ◽

10.1038/s41436-020-00995-w ◽

2020 ◽

Author(s):

Ye Zhu ◽

James P. Moriarty ◽

Kristi M. Swanson ◽

Paul Y. Takahashi ◽

Suzette J. Bielinski ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Disease Management ◽

Model Based ◽

Panel Testing ◽